No company in the United States has ever restarted a reactor that was seemingly closed for good, but there are now three major efforts underway to do so.
Two researchers who study the debilitating sleep disorder have won a prestigious Lasker Award. Their research in animals laid the groundwork for a new drug that addresses the conditionβs root cause.
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
Jacob Tsimerman, a recent recipient of the Fields Medal, believes that higher mathematics can help curb the dangers of runaway artificial intelligence.
Traditional gene editing rewrites DNA. But a new approach, called epigenome editing, aims to treat the molecular scars we collect throughout our lives.
Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.
Researchers want to explore the idea that microscopic particles shed by alien civilizations have accumulated on the lunar surface, making it an archive of extraterrestrial technology.
Under a new partnership, the Defense Department would play a larger role in biodefense and pandemic preparedness. Democrats warned it could allow a Pentagon cash grab.
They are moving too fast for the normal mind to keep up, but elite drivers have more densely packed brain cells where it counts and use their minds more efficiently.